Employers shun Pfizer, Astrazeneca COVID-19 vaccines

FILE PHOTO: A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

Employers express reluctance to use the 2019 Coronavirus Disease (COVID-19) vaccine of pharmaceutical companies Pfizer and AstraZeneca.

Employers Confederation of the Philippines (ECOP) president Sergio Ortiz-Luis Jr. said on Thursday, February 18, that business owners fear the possible adverse reaction of the vaccine to some elderly people and individuals with allergies.

Iyon yung bagong sistema. Iyon yung kinakatakutan nung maraming matatanda at saka yung mga ano, na baka may reaction doon. Natatakot sila,” Ortiz-Luis explained during DZRH’s Coffee Break.

Yung efficacy medyo mataas nga pero it is looking like na yung old style ng vaccine na hindi naapektuhan yung ano ng protein ay mas safer,” he added.

The vaccine of Pfizer utilizes a new technology which packs messenger RNA that instructs cells to make the spike protein, which triggers an immune response inside the body.

The shots of AstraZeneca, meanwhile, are classified as a viral vector vaccine, which makes use of a harmless virus to deliver a payload of genetic material that contains a blueprint to make the spike protein.

Authorities in the United States and the United Kingdom have reported that recipients of either COVID-19 vaccines of Pfizer, or AstraZeneca experienced some adverse effects including headache, and fatigue.

The Centers for Disease Control and Prevention of the United States even warned that some people suffered from anaphylaxis, a severe, life-threatening allergic reaction, after receiving the COVID-19 vaccine of Pfizer.

Leave a Comment

Your email address will not be published. Required fields are marked *